2.20

51.72% 0.75

After Hours: 2.56 0.36 +16.36%

Rani Therapeutics Holdings Inc (RANI)

Overview News Price History Option Chain Financials Discussions Forecast

Rani Therapeutics Holdings Inc stock is traded at $2.20, with a volume of 52.79M. It is up +51.72% in the last 24 hours and up +340.18% over the past month. Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Previous Close:

$1.45

Open:

$1.55

24h Volume:

52.79M

Relative Volume:

3.52

Market Cap:

$103.61M

Revenue:

$1.20M

Net Income/Loss:

$-52.41M

P/E Ratio:

-2.4176

EPS:

-0.91

Net Cash Flow:

$-31.25M

1W Performance:

+20.88%

1M Performance:

+340.18%

6M Performance:

+98.20%

1Y Performance:

-3.93%

1-Day Range:

$1.535

$2.40

1-Week Range:

$1.42

$2.40

52-Week Range:

$0.387

$3.87

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name

Rani Therapeutics Holdings Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(408) 457-3700

Address

2051 RINGWOOD AVENUE, SAN JOSE

Employee

106

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

RANI's Discussions on Twitter

Compare RANI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RANI Rani Therapeutics Holdings Inc	2.20	141.43M	1.20M	-52.41M	-31.25M	-0.91
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-02-24	Initiated	Oppenheimer	Outperform
Jun-14-24	Initiated	Maxim Group	Buy
Jun-13-24	Initiated	Rodman & Renshaw	Buy
Apr-17-23	Resumed	BTIG Research	Buy
Oct-11-22	Initiated	UBS	Buy
Jul-27-22	Initiated	H.C. Wainwright	Buy
Jun-13-22	Initiated	Wedbush	Outperform

View All

Rani Therapeutics Holdings Inc Stock (RANI) Latest News

02:47 AM

Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Performance Summary & Verified Chart Pattern Signals - newser.com

02:47 AM

Nov 01, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Nov 01, 2025

Institutional scanner results for Rani Therapeutics Holdings Inc.2025 Performance Recap & Technical Entry and Exit Alerts - newser.com

Nov 01, 2025

Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025July 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com

Nov 01, 2025

Rani Therapeutics’ Strategic Partnerships Elevate Market Presence - timothysykes.com

Nov 01, 2025

Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryWeekly Trade Analysis & Fast Gaining Stock Reports - newser.com

Nov 01, 2025

Oct 31, 2025

How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com

Oct 31, 2025

Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - MSN

Oct 31, 2025

Multi asset correlation models including Rani Therapeutics Holdings Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com

Oct 31, 2025

Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

Oct 31, 2025

Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthIPO Watch & Safe Capital Preservation Plans - newser.com

Oct 31, 2025

Short interest data insights for Rani Therapeutics Holdings Inc.Market Trend Summary & High Accuracy Swing Trade Signals - newser.com

Oct 31, 2025